Pf Webinars: Pharma and Integrated Care Systems – How to make your brand relevant
Pf is proud to announce a new FREE webinar series with Triducive. The first webinar, focuses on pharma and integrated care systems. In this...
Why are life science companies contracting market access activities?
Sathyanarayanan Krishnamurthy, Vice President – Regulatory Operations at Freyr Solutions looks at contracting out market access activities and how this frees up life sciences...
Mind the generation gap in pharma marketing and market research
Industry came together to explore the impact of the generation gap in pharma marketing and market research at BHBIA's summer event. Different generations have always...
PM Society Digital Award Winners 2019
Thursday 19th September saw the tenth PM Society Digital Awards take place at The Brewery in London. Around 500 guests sat down to dinner...
The art of customer experience management (CXM)
Magnus Franzen explains why customer experience management is essential to delivering what your customers need. Customer experience management (CXM) is both a discipline and a philosophy.
“ACROSS...
The key to engaging healthcare professionals effectively
Hank Sczerba on how to understand healthcare professionals in order to target them more effectively
Tell me about yourself and what you do? I am Head...
Improve your sales insight using AI
Will 2019 be the year in which pharma sales and marketing teams use augmented intelligence to successfully exploit infinite data? Buzz Lightyear made his first...
The impact of Brexit on the regulatory and marketing landscape
Brexit-related change will define the European pharmaceutical and healthcare sector in 2019, both in terms of how drug products are regulated and how they...
HFMA’s Chris Calkin on how the money in the NHS system works
How does the money flow through the NHS? Here’s the inside intelligence.
The complicated structure of the NHS is often impenetrable, even to those who...
New standards launched to improve public involvement in research
New national standards to improve the quality of public involvement in research.
Latest articles
New COVID-19 screening technology could test large groups with rapid response
The Technology Partnership Plc (TTP) is developing a new pooled screening technology for COVID-19 that can be used for the screening of large groups,...
Distribution and scaling up a Covid-19 vaccine
The development and distribution of a safe and effective vaccine is widely seen as the best resolution to the COVID-19 pandemic, and the most...
NICE recommends BRAFTOVI®▼(encorafenib) for previously treated adults with metastatic colorectal cancer
The National Institute for Health and Care Excellence (NICE) has issued a Final Appraisal Determination (FAD) recommending BRAFTOVI®▼(encorafenib) plus cetuximab, within its marketing authorisation, as...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
Nasal spray to protect against COVID-19 is ready for use in humans
A nasal spray to provide protection against the COVID-19 virus has been formulated by researchers at the University of Birmingham, UK, using compounds already...
Distribution and scaling up a Covid-19 vaccine
The development and distribution of a safe and effective vaccine is widely seen as the best resolution to the COVID-19 pandemic, and the most...
NICE recommends BRAFTOVI®▼(encorafenib) for previously treated adults with metastatic colorectal cancer
The National Institute for Health and Care Excellence (NICE) has issued a Final Appraisal Determination (FAD) recommending BRAFTOVI®▼(encorafenib) plus cetuximab, within its marketing authorisation, as...
New COVID-19 screening technology could test large groups with rapid response
The Technology Partnership Plc (TTP) is developing a new pooled screening technology for COVID-19 that can be used for the screening of large groups,...